المؤلفون: Shah P; Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Forget MA; Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Biologics Development, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Frank ML; Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Jiang P; Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sakellariou-Thompson D; Biologics Development, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Federico L; Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Khairullah R; Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Neutzler CA; Biologics Development, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wistuba I; Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Chow CB; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Long Y; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Fujimoto J; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Lin SY; Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Maitra A; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Negrao MV; Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Mitchell KG; Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Weissferdt A; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Vaporciyan AA; Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Cascone T; Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Roth JA; Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Zhang J; Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sepesi B; Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gibbons DL; Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Heymach JV; Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Haymaker CL; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., McGrail DJ; Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA cbernatchez@mdanderson.org AReuben@mdanderson.org djmcgrail@mdanderson.org., Reuben A; Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA cbernatchez@mdanderson.org AReuben@mdanderson.org djmcgrail@mdanderson.org., Bernatchez C; Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA cbernatchez@mdanderson.org AReuben@mdanderson.org djmcgrail@mdanderson.org.; Biologics Development, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Feb; Vol. 10 (2).

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: CD3 Complex/*immunology , Carcinoma, Non-Small-Cell Lung/*genetics , Interleukin-2/*metabolism , Lung Neoplasms/*genetics , Lymphocytes, Tumor-Infiltrating/*immunology , Translational Research, Biomedical/*methods , Tumor Necrosis Factor Receptor Superfamily, Member 9/*immunology, Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung/pathology ; Female ; Humans ; Lung Neoplasms/pathology ; Male ; Middle Aged

المؤلفون: Sousa LG; The University of Texas MD Anderson Cancer Center Department of Thoracic Head and Neck Medical Oncology, Houston, Texas, USA., Rajapakshe K; Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rodriguez Canales J; Translational Medicine, AstraZeneca, Gaithersburg, Maryland, USA., Chin RL; Department of Immunology and Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas, USA.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Feng L; Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang Q; Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Barrese TZ; Grupo Fleury, Sao Paulo, Brazil., Massarelli E; Medical Oncology, City of Hope National Medical Center, Duarte, California, USA., William W; Departmento de Oncologia e Hematologia, Centro Oncológico BP Beneficência Portuguesa de São Paulo, Sao Paulo, Brazil., Johnson FM; The University of Texas MD Anderson Cancer Center Department of Thoracic Head and Neck Medical Oncology, Houston, Texas, USA., Ferrarotto R; The University of Texas MD Anderson Cancer Center Department of Thoracic Head and Neck Medical Oncology, Houston, Texas, USA., Wistuba I; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Coarfa C; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA., Lee J; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang J; Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Melief CJM; ISA Pharmaceuticals, Leiden, The Netherlands., Curran MA; Department of Immunology and Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, Texas, USA mcurran@mdanderson.org.; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Glisson BS; The University of Texas MD Anderson Cancer Center Department of Thoracic Head and Neck Medical Oncology, Houston, Texas, USA.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Feb; Vol. 10 (2).

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents, Immunological/*therapeutic use , Human papillomavirus 16/*drug effects , Human papillomavirus 16/*immunology , Immunity/*immunology , Nivolumab/*therapeutic use, Antineoplastic Agents, Immunological/pharmacology ; Female ; Humans ; Male ; Nivolumab/pharmacology

المؤلفون: Taube JM; Department of Dermatology, The Johns Hopkins Hospital, Baltimore, Maryland, USA jtaube1@jhmi.edu., Roman K; Akoya Biosciences, Marlborough, Massachusetts, USA., Engle EL; Department of Dermatology, The Johns Hopkins Hospital, Baltimore, Maryland, USA., Wang C; Akoya Biosciences, Marlborough, Massachusetts, USA., Ballesteros-Merino C; Department of Molecular Microbiology and Immunology, Providence Cancer Institute, Earle A. Chiles Research Institute, Portland, Oregon, USA., Jensen SM; Department of Molecular Microbiology and Immunology, Providence Cancer Institute, Earle A. Chiles Research Institute, Portland, Oregon, USA., McGuire J; Akoya Biosciences, Marlborough, Massachusetts, USA., Jiang M; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Coltharp C; Akoya Biosciences, Marlborough, Massachusetts, USA., Remeniuk B; Akoya Biosciences, Marlborough, Massachusetts, USA., Wistuba I; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Locke D; Bristol Myers Squibb, Princeton, New Jersey, USA., Parra ER; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Fox BA; Department of Molecular Microbiology and Immunology, Providence Cancer Institute, Earle A. Chiles Research Institute, Portland, Oregon, USA., Rimm DL; Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA., Hoyt C; Akoya Biosciences, Marlborough, Massachusetts, USA.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Jul; Vol. 9 (7).

نوع المنشور: Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*metabolism , Fluorescent Antibody Technique/*methods , Immunohistochemistry/*methods , Laboratories, Clinical/*standards , Tissue Array Analysis/*methods, Female ; Humans ; Male

المؤلفون: Tapia C; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA ctapia@epizyme.com.; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Aung PP; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Roy-Chowdhuri S; Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Xu M; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ouyang F; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Alshawa A; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hajjar J; Section of Immunology, Allergy and Rheumatology, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA., Singh G; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yang V; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Castillo L; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Le H; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Murthy R; Department of Interventional Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Stephen B; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hess KR; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wistuba I; Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Naing A; Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

المصدر: Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Apr; Vol. 8 (1).

نوع المنشور: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antibodies, Monoclonal, Humanized/*administration & dosage , Antineoplastic Agents, Immunological/*administration & dosage , Biomarkers, Tumor/*analysis , Neoplasms/*diagnosis , Rare Diseases/*diagnosis, Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Humanized/adverse effects ; Antineoplastic Agents, Immunological/adverse effects ; Biopsy ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Neoplasms/drug therapy ; Neoplasms/immunology ; Neoplasms/pathology ; Prognosis ; Rare Diseases/drug therapy ; Rare Diseases/immunology ; Rare Diseases/pathology ; Treatment Outcome ; Young Adult